Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation

被引：0
|
作者：
Ines Greco
Nicola Day
Joanna Riddoch-Contreras
Jane Reed
Hilkka Soininen
Iwona Kłoszewska
Magda Tsolaki
Bruno Vellas
Christian Spenger
Patrizia Mecocci
Lars-Olof Wahlund
Andrew Simmons
Julie Barnes
Simon Lovestone
机构：
[1] Institute of Psychiatry,King’s College London
[2] BioWisdom Ltd,now Instem Scientific
[3] University of Eastern Finland and University Hospital of Kuopio,3rd Department of Neurology, "G. Papanicolaou" Hospital
[4] Medical University of Lodz,UMR INSERM 1027, Gerontopole, CHU Toulouse
[5] Aristotle University of Thessaloniki,Department of Clinical Science, Intervention and Technology
[6] University of Toulouse,Institute of Gerontology and Geriatrics
[7] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society
[8] University of Perugia,undefined
[9] Karolinska Institutet,undefined
[10] Currently at Somaxa Ltd and Abcodia Ltd,undefined
来源：
Journal of Translational Medicine | / 10卷
关键词：
Alzheimer’s disease; Proteomics; Biomarkers; Choline acetyltransferase (ChAt); Urokinase-type plasminogen activator receptor (PLAUR); Intelligence network; Bioinformatics; MRI; Literature mining;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease
    Jack, Clifford R., Jr.
    Barkhof, Frederik
    Bernstein, Matt A.
    Cantillon, Marc
    Cole, Patricia E.
    DeCarli, Charles
    Dubois, Bruno
    Duchesne, Simon
    Fox, Nick C.
    Frisoni, Giovanni B.
    Hampel, Harald
    Hill, Derek L. G.
    Johnson, Keith
    Mangin, Jean-Francois
    Scheltens, Philip
    Schwarz, Adam J.
    Sperling, Reisa
    Suhy, Joyce
    Thompson, Paul M.
    Weiner, Michael
    Foster, Norman L.
    ALZHEIMERS & DEMENTIA, 2011, 7 (04) : 474 - 485
  • [12] AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation
    Mai, Yingren
    Yu, Qun
    Zhu, Feiqi
    Luo, Yishan
    Liao, Wang
    Zhao, Lei
    Xu, Chunyan
    Fang, Wenli
    Ruan, Yuting
    Cao, Zhiyu
    Lei, Ming
    Au, Lisa
    Mok, Vincent C. T.
    Shi, Lin
    Liu, Jun
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (03) : 1022 - 1032
  • [13] Phytochemicals for Drug Discovery in Alzheimer's Disease: In Silico Advances
    Sharma, Smriti
    Bhatia, Vinayak
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (25) : 2848 - 2860
  • [14] Dataset of why inclusion matters for Alzheimer's disease biomarker discovery in plasma
    Khan, Mostafa J.
    Desaire, Heather
    Lopez, Oscar L.
    Kamboh, M. Ilyas
    Robinson, Rena A. S.
    DATA IN BRIEF, 2021, 35
  • [15] The early diagnosis of Alzheimer's disease: Blood-based panel biomarker discovery by proteomics and metabolomics
    Dong, Yun
    Song, Xun
    Wang, Xiao
    Wang, Shaoxiang
    He, Zhendan
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (11)
  • [16] Cognitive biomarker prioritization in Alzheimer's Disease using brain morphometric data
    Peng, Bo
    Yao, Xiaohui
    Risacher, Shannon L.
    Saykin, Andrew J.
    Shen, Li
    Ning, Xia
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2020, 20 (01)
  • [17] Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases
    Cilento, Eugene M.
    Jin, Lorrain
    Stewart, Tessandra
    Shi, Min
    Sheng, Lifu
    Zhang, Jing
    JOURNAL OF NEUROCHEMISTRY, 2019, 151 (04) : 397 - 416
  • [18] Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease
    William T. Hu
    Alice Chen-Plotkin
    Steven E. Arnold
    Murray Grossman
    Christopher M. Clark
    Leslie M. Shaw
    Leo McCluskey
    Lauren Elman
    Jason Karlawish
    Howard I. Hurtig
    Andrew Siderowf
    Virginia M.-Y. Lee
    Holly Soares
    John Q. Trojanowski
    Acta Neuropathologica, 2010, 120 : 385 - 399
  • [19] Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    ACTA NEUROPATHOLOGICA, 2010, 120 (03) : 385 - 399
  • [20] Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study
    Hok-A-Hin, Yanaika S. S.
    Bolsewig, Katharina
    Ruiters, Daimy N. N.
    Lleo, Alberto
    Alcolea, Daniel
    Lemstra, Afina W. W.
    van der Flier, Wiesje M. M.
    Teunissen, Charlotte E. E.
    del Campo, Marta
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (03)
12345